Childhood cancer survivor study doubles to examine late effects of new treatments.
Twombly
Renee
R
D000970:Antineoplastic Agents / Q000009:adverse effects; D001932:Brain Neoplasms / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control; D001943:Breast Neoplasms / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control; D002648:Child; D005260:Female; D006304:Health Status; D006801:Humans; D015994:Incidence; D008913:Minority Groups / Q000706:statistics & numerical data; D009369:Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D016609:Neoplasms, Second Primary / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control; D011788:Quality of Life; D011878:Radiotherapy / Q000009:adverse effects; D011795:Surveys and Questionnaires; D017741:Survivors; D014481:United States / Q000453:epidemiology
D000970:Antineoplastic Agents